TET1 loss promotes malignant phenotypes in HeLa cells and is associated with altered PTEN–PI3K/AKT/mTOR signaling
Reduced TET1 expression was observed in SCC-restricted public cohorts, while TET1 depletion promoted malignant phenotypes in HeLa cells, which identifies a candidate signaling association that warrants validation through rescue experiments and locus-specific epigenetic studies.